FDA Class II Recall Targets 51,762 ORL Labs Oral Care Units for Hormone Contamination

3 min read
Source: USA Today
FDA Class II Recall Targets 51,762 ORL Labs Oral Care Units for Hormone Contamination
Photo: USA Today
TL;DR

ORL Labs LLC has voluntarily recalled 51,762 units of toothpaste and mouthwash nationwide after the FDA detected hormones in product samples. The Class II recall, initiated on October 12 and classified on November 6, covers six products with expiration dates between September 2026 and August 2028. The FDA did not specify hormone concentrations or the cause of cross-contamination, and no consumer health instructions were provided in the report.

Key points

  • The recall involves 51,762 units of six ORL Organic Oral Care products, including Fresh Mint, Cinnamint, and Bubblegum Kids varieties for adults and children.
  • FDA testing identified progesterone, estradiol, or dehydroepiandrosterone (DHEA) in samples, though specific hormones and concentrations were not disclosed.
  • The recall was initiated on October 12 and classified as Class II on November 6, indicating potential for temporary or medically reversible adverse health consequences.
  • ORL Labs, based in Scottsdale, Arizona, notified the public via letter rather than a press release and did not respond to media inquiries.
  • The FDA report lacks guidance on product disposal or refunds, leaving consumers to contact the company directly for assistance.

Background

This recall follows a broader trend of oral care product issues, including a 2026 recall of 4.3 million toothpaste tubes by Ashtel Studios Inc. due to manufacturing deviations. While the current issue involves hormone contamination, previous recalls have focused on good manufacturing practice deviations. The FDA’s Class II classification suggests a lower risk profile compared to Class I recalls, but the presence of hormones in oral care products raises concerns about cross-contamination in production.

How outlets are covering it

USA TODAY, Fox Business, and international outlets like cwibc.co.id and Peradaban.id uniformly report the recall details, including the number of units, affected products, and FDA classification. All sources note the lack of specific hormone identification and the absence of consumer instructions in the FDA report. Fox Business provides additional context on the hormones involved, explaining that progesterone and estradiol are female sex hormones, while DHEA is used to produce estrogen and testosterone. No outlet reports on consumer health impacts or company responses, as ORL Labs did not issue a press release or respond to inquiries.

Why it matters

The recall highlights potential cross-contamination risks in oral care product manufacturing, which could affect consumer safety. While the FDA classifies the recall as Class II, the presence of hormones in toothpaste and mouthwash raises questions about production standards and the need for clearer consumer guidance. The lack of disposal or refund instructions may lead to confusion among consumers, potentially affecting trust in the brand and the regulatory process.

What to watch

Consumers should check their products against the affected lot numbers and UPCs listed in the FDA report. Those with questions can contact ORL Labs at 844-675-5227 or [email protected]. The FDA may provide further updates on the recall, including potential health risks or additional testing results. ORL Labs may issue a statement or press release in response to media inquiries, though no response has been reported as of November 20, 2026.

Share this article

Want the full story? Read the original reporting

Read on USA Today